Emerging Targets Ion Channels Drug Discovery Conference & Exposition to Take Place May 20-21, 2002, in Princeton, NJ

The latest developments in Ion Channel research at the discovery, preclinical, and clinical stages will be the focus of the first-ever Ion Channels in Drug Discovery & Development" taking place in Princeton, NJ on May 20-21, 2002, announces Strategic Research Institute.

PRINCETON, N.J., March 27 --

The latest developments in Ion Channel research at the discovery, preclinical, and clinical stages will be the focus of the first-ever Ion Channels in Drug Discovery & Development" taking place in Princeton, NJ on May 20-21, 2002, announces Strategic Research Institute.

Research over the past decade has revealed that ion channels have therapeutic potential in a number of diseases such as Parkinson's, Alzheimer's, neuropathic pain, sickle cell disease, and many others. The meeting, divided into three discrete sections, 1) automated electrophysiology, 2) emerging targets & pharmacology, 3) preclinical & clinical development of Ion Channel compounds, will feature the top researchers pharmaceutical, biotech, and academic scientists revealing their newest findings.

Highlights of the meeting include:

-Structure, Function, and Molecular Pharmacology of Voltage-gated Sodium Channels
Dr. William Catterall, Professor, UNIVERSITY OF WASHINGTON

-Modulation of Kv Channels: Novel Approaches, Subunits, and Pharmacology
WYETH-AYERST RESEARCH

-The Role of Voltage-gated Potassium Channel Kv1.3 in Human T Cells: a Target for Immunosuppression
MERCK RESEARCH LABORATORIES

Presenting papers on behalf of the industry will be Abbott Laboratories, AstraZeneca R&D, Bristol-Myers Squibb, Merck Research Laboratories, Millennium Pharmaceuticals, Aurora Biosciences, Aviva Biosciences, Axon Instruments, CeNeS, Icagen, Molecular Devices, NeuroSearch, and Sophion Biosciences. Harvard University, Howard Hughes Medical Institute, National Institutes of Health, and the University of Washington will represent the academia.

REGISTRATION:

To register, or receive more information, phone 888-666-8514 or 646-336-7030 or visit our web site at www.srinstitute.com/cs210.

AGENDA:
To receive the full agenda in PDF format, please contact Jon E. Liong of Strategic Research Institute at jliong@srinstitute.com or 212-967-0095, x243 (please include name, corporate affiliation, mailing address, email, and fax number).

EXPOSITION:

For more information on the exposition, or to register as a sponsor please contact Mark Alexay at malexay@srinstitute.com.

Contact:

Jon E. Liong
Producer, Pharmaceutical Division
Strategic Research Institute
212-967-0095, ext. 243
jliong@srinstitute.com
www.srinstitute.com/CS210